Our THRIVE Clinical Studies.

Helping to develop potential new treatments for Thyroid Eye Disease.

THRIVE Clinical Studies

A doctor filling a medicine bottle with a syringe.

THRIVE is for people diagnosed with moderate to severe active TED.

THRIVE-2 is for people diagnosed with moderate to severe chronic TED. 

Who can I contact for more information?

To learn more about THRIVE and THRIVE-2, please contact your doctor.

For additional information about the study sponsor, Viridian Therapeutics, please email patientadvocacy@viridiantherapeutics.com